Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Bone Marrow Microenvironment Mechanisms in Acute Myeloid Leukemia
Débora Bifano Pimenta, Vanessa Araújo Varela, Tarcila Santos Datoguia, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 40

Showing 1-25 of 40 citing articles:

CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang, Lingling Zhu, Hui Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 218
The cytokine network in acute myeloid leukemia
Michela Luciano, Peter W. Krenn, Jutta Horejs‐Hoeck
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Preclinical Evaluation of CRISPR-Edited CAR-NK-92 Cells for Off-the-Shelf Treatment of AML and B-ALL
Guillermo Ureña-Bailén, Jérôme-Maurice Dobrowolski, Yujuan Hou, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12828-12828
Open Access | Times Cited: 33
Immunotherapies of acute myeloid leukemia: Rationale, clinical evidence and perspective
Yunyi Wu, Yanchun Li, Yan Gao, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 171, pp. 116132-116132
Open Access | Times Cited: 8
Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies
Wioletta Olejarz, Karol Sadowski, Daniel Szulczyk, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 14, pp. 7743-7743
Open Access | Times Cited: 8
Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
Edoardo Peroni, Maria Luigia Randi, Antonio Rosato, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
The Clinical Significance and Involvement in Molecular Cancer Processes of Chemokine CXCL1 in Selected Tumors
Jan Korbecki, Mateusz Bosiacki, Iwona Szatkowska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 8, pp. 4365-4365
Open Access | Times Cited: 6
Harnessing upregulated E-selectin while enhancing SDF-1α sensing redirects infused NK cells to the AML-perturbed bone marrow
Laura Sanz-Ortega, Agneta Andersson, Mattias Carlsten
Leukemia (2024) Vol. 38, Iss. 3, pp. 579-589
Open Access | Times Cited: 4
In Vitro 3D Models of Haematological Malignancies: Current Trends and the Road Ahead?
Carlotta Mattioda, Claudia Voena, Gianluca Ciardelli, et al.
Cells (2025) Vol. 14, Iss. 1, pp. 38-38
Open Access
Construction of a stromal-related prognostic model in acute myeloid leukemia by comprehensive bioinformatics analysis
Laya Khodayi Hajipirloo, Maryam Nabigol, Reza Khayami, et al.
Current Research in Translational Medicine (2025) Vol. 73, Iss. 2, pp. 103492-103492
Closed Access
Stem cell status and prognostic applications of cuproptosis-associated lncRNAs in acute myeloid leukemia
Zhuodong Chai, Zhongyue Yuan, Yifei Chen
Frontiers in Cell and Developmental Biology (2025) Vol. 12
Open Access
MMP14 from BM-MSCs facilitates progression and Ara-C resistance in acute myeloid leukemia via the JAK/STAT pathway
Jinxian Wu, Xinqi Li, Ying Liu, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
SAA1 Protein: A Potential Biomarker for Acute Myeloid Leukemia
Pedro Leite Azevedo, Mayara de Azeredo Rezende, Marie‐Anne Félix, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 880-880
Open Access
Molecular Genetic Analysis of Bone Marrow Core Biopsy as an Alternative or Adjunct to Bone Marrow Aspirate and/or Peripheral Blood in Hematologic Myeloid Neoplasms
Klaus Hirschbühl, Bruno Märkl, Gernot Müller, et al.
Diagnostics (2025) Vol. 15, Iss. 8, pp. 991-991
Open Access
The challenges of managing acute myeloid leukemia in pediatric patients: a review of current treatment strategies
Ashutosh Kumar Verma, Neha Shrivastava
International Journal of Research in Medical Sciences (2025)
Open Access
Circadian rhythm and aryl hydrocarbon receptor crosstalk in bone marrow adipose tissue and implications in leukemia
Bihter Muratoğlu, Cansu Özdemir, Cemil Can Eylem, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Macrophages as Potential Therapeutic Targets in Acute Myeloid Leukemia
Oana Mesaros, Madalina Onciul, Emilia Grigorescu, et al.
Biomedicines (2024) Vol. 12, Iss. 10, pp. 2306-2306
Open Access | Times Cited: 3
Crosstalk between DNA methylation and hypoxia in acute myeloid leukaemia
Sam Humphries, Danielle R. Bond, Zacary P. Germon, et al.
Clinical Epigenetics (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
Gaia Alberti, Corinne Arsuffi, Alice Pievani, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 7
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche
Deng Ju, Yanhong Tan, Zhifang Xu, et al.
Annals of Hematology (2024)
Closed Access | Times Cited: 2
Recent Developments and Challenges in the Treatment of Acute Leukemia and Myelodysplastic Syndromes: A Systematic Review
Nawal Rafiq, Muhammad H Khan, Mashaal Sahibzada, et al.
Cureus (2024)
Open Access | Times Cited: 2
Fabrication of a three-dimensional bone marrow niche-like acute myeloid Leukemia disease model by an automated and controlled process using a robotic multicellular bioprinting system
Dana Alhattab, Ioannis Isaioglou, Salwa Alshehri, et al.
Biomaterials Research (2023) Vol. 27, Iss. 1
Open Access | Times Cited: 6
Progress toward Better Treatment of Therapy-Related AML
Angeliki Kotsiafti, Konstantinos Giannakas, Panagiotis Christoforou, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1658-1658
Open Access | Times Cited: 4
The Contribution of Multiplexing Single Cell RNA Sequencing in Acute Myeloid Leukemia
Lamia Madaci, Charlyne Gard, Sébastien Nin, et al.
Diseases (2023) Vol. 11, Iss. 3, pp. 96-96
Open Access | Times Cited: 4
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling
Chiara Tomasoni, Corinne Arsuffi, Samantha Donsante, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top